Sunisam Capsules: Product Information, Strengths and FAQs for Singapore

Sunisam Capsules – Product Overview

Sunisam Capsules are an oral prescription medicine containing sunitinib, an anticancer agent belonging to the tyrosine kinase inhibitor (TKI) class. Product listings from Indian medicine retailers identify Sunisam as a sunitinib-based formulation. It is used under specialist supervision for certain cancers, depending on the approved product information and clinical circumstances.

For individuals and healthcare procurement professionals in Singapore researching Sunisam Capsules online, it is important to verify the product's composition, strength, manufacturer details, packaging and regulatory status before considering any supply arrangement.

Sunisam Capsules: Composition and Available Strengths

The active ingredient reported for Sunisam Capsules is sunitinib. Online product listings identify the following strengths:

Sunisam 12.5 mg Capsules

Sunisam 25 mg Capsules

Sunisam 50 mg Capsules

These strengths are listed by Indian pharmaceutical medicine retailers. Availability in Singapore, local registration and authorised supply have not been independently confirmed. Always check the actual packaging and current product documentation before relying on these details.

Sunitinib is a targeted anticancer medicine that works by inhibiting certain enzymes involved in cell growth and the development of blood vessels that supply tumours. Its use depends on the specific diagnosis, treatment history and the prescribing specialist's assessment.

Product Information for Singapore

When researching Sunisam Capsules in Singapore, buyers and healthcare professionals should review the following information:

Active ingredient: Sunitinib.

Dosage form: Oral capsule.

Strengths listed overseas: 12.5 mg, 25 mg and 50 mg.

Therapeutic category: Antineoplastic medicine; tyrosine kinase inhibitor.

Prescription status: Requires specialist medical supervision.

Regulatory status: Must be verified with Singapore's Health Sciences Authority (HSA).

Do not assume that overseas product availability means a medicine is registered or approved for sale in Singapore. Importation and supply must comply with applicable Singapore requirements.

Frequently Asked Questions About Sunisam Capsules

1. What are Sunisam Capsules?

Sunisam is a sunitinib-containing prescription medicine listed in overseas product references. It is used for certain cancers under the direction of an appropriately qualified healthcare professional.

2. What strengths of Sunisam Capsules are listed online?

Overseas listings identify 12.5 mg, 25 mg and 50 mg strengths. Confirm the strength against the manufacturer's packaging and product documentation.

3. What is sunitinib used for?

Depending on the approved indication, sunitinib may be prescribed for certain gastrointestinal stromal tumours, advanced kidney cancer and pancreatic neuroendocrine tumours. Treatment suitability must be determined by an oncology specialist.

4. Can Sunisam Capsules be purchased online in Singapore?

Do not assume online listings are authorised for Singapore. Check the medicine's registration status and obtain guidance from a licensed healthcare professional or pharmacist before pursuing any supply.

5. What precautions apply to Sunisam Capsules?

Sunitinib can cause significant adverse effects and drug interactions. Treatment may require monitoring of blood pressure, blood counts, liver function and other clinical parameters. Patients should discuss pregnancy, existing medical conditions and all other medicines with their treating specialist.

6. How can buyers verify product authenticity?

Check the manufacturer's details, batch number, expiry date, packaging integrity and accompanying product documentation. Use authorised supply channels and verify applicable Singapore import and registration requirements.

Important Regulatory Notice

This page provides general product information and is not a substitute for medical advice. Sunisam Capsules must not be self-prescribed or used without specialist supervision. Before publishing this page for Singapore audiences, verify all product claims and regulatory requirements with the relevant authorities. Public advertising of prescription-only medicines is prohibited in Singapore under applicable HSA rules.